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Aims The aim of this study was to investigate whether circumferential pulmonary vein (PV) isolation guided by image inte-
gration improves the procedural and clinical outcomes of atrial fibrillation (AF) ablation in comparison with segmental
PV isolation and circumferential PV isolation guided by three-dimensional (3D) electroanatomical mapping alone.
Methods
and results
Procedural and clinical outcomes of 573 patients who underwent their first catheter ablation for paroxysmal AF
between January 2005 and April 2007 were collected from 12 centres. We evaluated three techniques: segmental
ostial PV isolation (SOCA group, 240 patients), circumferential PV isolation guided by electroanatomical mapping
(CARTO group, 107 patients), and circumferential PV isolation guided by electroanatomical mapping integrated
with magnetic resonance/computed tomographic images of the left atrium (MERGE group, 226 patients). Procedure
duration proved to be shorter in MERGE group patients than in CARTO group patients (P, 0.04), but longer than in
SOCA group patients (P, 0.0001). During follow-up, atrial tachyarrhythmias relapsed more frequently in SOCA
group patients (44.6%) and CARTO group patients (41.7%) than in MERGE group patients (22.6%; P, 0.0001).
Conclusion In patients with paroxysmal AF, circumferential PV isolation guided by image integration significantly improves clinical
outcome in comparison with both circumferential PV isolation guided by 3D mapping alone and with segmental elec-
trophysiologically guided PV isolation.
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Introduction
Since the discovery of the pivotal role of the pulmonary veins (PVs)
in initiating and perpetuating atrial fibrillation (AF), several strategies
for performing AF radiofrequency (RF) catheter ablation have been
proposed.1 –3 New ablation strategies are mainly based on anatomy
and properly require the placement of ablation lesions at well-
defined anatomic locations, namely around the veno-atrial junc-
tions.3 –7 However, variations in PV anatomy are common,8 and a
detailed understanding of left atrial anatomy is required in order
to maximize the safety and efficacy of the procedure.
Hence, a new technique that enables high-resolution images from
magnetic resonance (MR) or computed tomographic (CT) imaging
to be integrated into three-dimensional (3D) electroanatomical
mapping systems has been introduced into clinical practice.9– 12 To
date, the impact of this new technique on the clinical outcome of
AF ablation has been demonstrated only in small single-centre
series.13,14
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The aim of this retrospective, controlled, multicentre study was
to investigate whether circumferential PV isolation guided by elec-
troanatomical mapping combined with image integration improves
the procedural and clinical outcomes of RF catheter ablation in
comparison with segmental PV isolation and with circumferential
PV isolation guided by 3D electroanatomical mapping alone in a
large cohort of patients suffering from symptomatic
drug-refractory paroxysmal AF.
Methods
Patients
The study population consisted of 573 consecutive patients highly
symptomatic for documented paroxysmal AF refractory to more
than one antiarrhythmic drug who underwent a first catheter
ablation from January 2005 to April 2007 in 12 Italian institutions
(see Appendix). We considered only paroxysmal AF patients in
order to evaluate the efficacy of PV isolation alone.
Three types of catheter ablation technique were included; all aimed
to achieve PV isolation documented by the circular mapping catheter:
segmental ostial PV isolation (SOCA group, 240 patients); circumferen-
tial antral PV isolation guided by 3D electroanatomical mapping
(CARTO group, 107 patients); and circumferential antral PV isolation
guided by electroanatomical mapping integrated with MR/CT images
of the left atrium (LA) (MERGE group, 226 patients).
In order to take in account the experience of each centre, we
compare the percentage of ablation performed during the first
14 months of the study period (early phase) and during the last
14 months (late phase) in each group.
This observational study was approved by each institution’s review
committee, and all patients provided written informed consent to
the ablation procedure.
Magnetic resonance/computed tomographic
imaging
MERGE group patients underwent Gadolinium-enhanced MR (n ¼ 45)
or multislice helical CT (n ¼ 181) imaging of the LA and PVs in the
post-absorptive state within 7 days before RF ablation.
Magnetic resonance studies were performed on a 1.5 T imaging
system (ACS InteraTM, Philips, Germany; Signa Excite HDx, General
Electric Healthcare Technologies, WI, USA). Magnetic resonance
angiograms were obtained with a normal-breath fast-field gradient
echo imaging sequence in the coronal plane. Acquisition time was
40 s. Slices of 1.5 mm thickness were acquired.
Computed tomographic scans were performed with a 16-slice or a
64-slice multidetector—CT (Light Speed Pro, General Electric Health-
care Technologies; Acquilion 64, Toshiba, Tokyo, Japan; Sensation 16,
Siemens, Erlangen, Germany) scanner in accordance with the following
protocol: a bolus of 130 cc iodate contrast agent was injected intrave-
nously at an infusion rate of 1.2 mL/s. After a 100 s delay, acquisition of
the CT data started automatically.
Detector collimation was 8  1.25 mm, and tube voltage was
120 kV at a current of 600 mA during diastole and a reduction of
current by 80% for the remaining time of the cardiac cycle in order
to reduce the radiation dose by 4 mSv. The CT scan was performed
by using prospective-gating at the breath-hold in the inspiratory phase
in patients in sinus rhythm (75% of the cycle) and without gating in
patients in AF.
Electrophysiological study
Prior to the electrophysiological study, transoesophageal echocardio-
graphy was performed 24–48 h before ablation in each patient to
exclude LA thrombus. Patients were studied in a conscious state; a
bolus of pethidine, midazolam, or propofol was administered in the
event of intolerable pain during ablation. One quadripolar or decapolar
catheter was inserted into the coronary sinus from the femoral,
jugular, or antecubital vein. Single or double transseptal puncture
was performed, according to the operator’s preference, under fluoro-
scopic guidance. The ablation catheter and decapolar circular mapping
catheter (LassoTM, Biosense Webster Inc., Diamond Bar, CA, USA, or
SpiralTM, St Jude Medical Inc., Minnetonka, MN, USA) were inserted
into the LA through one or two long vascular sheaths.
After crossing the atrial septum, an initial intravenous bolus of
100 IU heparin/kg was administered, followed by continuous infusion
of 1000 IU/h in order to maintain the activated clotting time
between 300 and 400 s.
Integration of magnetic resonance/computed
tomographic images into the three-dimensional
mapping system
The MR/CT image was imported into a novel version of the electroa-
natomical mapping system (CartoTM XP, Biosense Webster Inc.)
equipped with a custom-designed software (CartomergeTM, Biosense
Webster Inc.).
Proprietary software tools on the electroanatomical mapping
system allow segmentation of the cardiac image to separate the LA
and the PVs from the surrounding cardiac structures. Images of the
LA and the PVs were then exported into the real-time mapping
system for registration.11–15
The CARTO system superimposed the 3D MR/CT LA surface
reconstruction onto the real-time LA electroanatomical map by
means of two algorithms. The first, called ‘landmark registration’,
approximated the electroanatomical map to the 3D MR/CT surface
reconstruction by matching the landmark pairs. The second, called
‘surface registration’, fitted the 3D MR/CT surface reconstruction to
the points on the electroanatomical map by rendering the smaller
average distance of the two data sets. Two different registration strat-
egies were adopted, according to the operator’s preference.13,15
The electroanatomical map was regarded as the gold standard with
which the MR/CT accuracy of fit was compared. Closeness of fit was
defined in terms of the mean distance between all electroanatomical
map points and the 3D MR/CT surface (surface-to-point distance).
Individual points with an error .5 mm were deleted.
Catheter ablation
The three catheter ablation strategies were all aimed at obtaining PV
isolation documented by the circular mapping catheter. The PV was
deemed isolated when PV potentials disappeared or were discon-
nected (entry block), and when pacing with a stimulus of twice the
amplitude of the stimulation threshold and of 2 ms duration from all
five bipolar electrodes of the circular mapping catheter enabled local
capture without LA capture (exit block).
SOCA group
In SOCA group patients, a decapolar circular mapping catheter and a
3.5 mm cooled-tip ablation catheter (Celsius, ThermocoolTM, Biosense
Webster) or an 8 mm tip ablation catheter (Celsius, Biosense
Webster) were inserted simultaneously into the LA. Once the ablation
catheter had entered the PV, the circular catheter was positioned as
close to the PV ostium as possible. Circular mapping was performed
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by obtaining five bipolar electrograms (1 to 2, 3 to 4, etc. up to 10 for
each pair of electrodes) from the circularly arranged electrodes of the
mapping catheter. Pulmonary vein isolation was achieved by applying
RF at the ostial sites showing electrical breakthroughs.16 Radiofre-
quency was applied in a power-controlled mode with a temperature
setting up to 458C, RF energy up to 38 W, and an irrigation rate up
to 30 mL/min, while using the 3.5 mm cooled-tip catheter; in the
case of the 8 mm tip catheter, the temperature was set up to 558C
and RF energy up to 60 W.
CARTO group
For circumferential PV ablation guided by 3D electroanatomical
mapping, once the mapping catheter (Navistar ThermoCool, Biosense
Webster Inc.) had been inserted into the LA, mapping of the LA was
performed as described previously.17
Radiofrequency pulses were delivered by means of a 3.5 mm
cooled-tip catheter (Navistar ThermoCool, Biosense Webster Inc.)
in a power-controlled mode, as described above. The aim of RF appli-
cations was to reduce local bipolar voltage either by 80% or to
,0.1 mV at the ablation sites.3 The ablation strategy consisted of
creating contiguous focal lesions at a distance 5 mm from the ostia
of the PVs, thereby forming a circumferential line of conduction
block around each PV or around ipsilateral PVs according to the
anatomy (Figure 1).17 On completion of circumferential ablation, a dec-
apolar circular catheter was placed at the PV ostium for PV potential
mapping. If PV potentials were still present, segmental ostial ablation
targeting the electrical breakthroughs was performed under the gui-
dance of circular mapping, with the aim of PV isolation.
MERGE group
For circumferential PV isolation guided by electroanatomical mapping
combined with image integration, image registration was followed by
RF pulse delivery by means of a 3.5 mm cooled-tip catheter (Navistar
ThermoCool, Biosense Webster Inc.) as described above (Figure 2).
On completion of circumferential ablation, a circular catheter was
placed at the PV ostium to map PV potentials, and segmental ostial
ablation targeting the electrical breakthroughs was performed.
Follow-up
After RF ablation, heparin infusion was discontinued until the activated
clotting time spontaneously fell to ,200 s, in order to withdraw the
introducers. Heparin infusion was restarted 2 h later and continued
until the normalized ratio was .2.0. Generally, warfarin was discontin-
ued after 3 months in the absence of atrial tachyarrhythmia recur-
rences. Cardiac rhythm was continuously monitored during the first
36–48 h. On discharge, transthoracic echocardiography was repeated
in order to evaluate the mitral valve and the left ventricular ejection
fraction, and to exclude the presence of pericardial effusion.
Follow-up examinations were scheduled at 3, 6, 12, and 18 months.
At each follow-up examination, the arrhythmia burden was assessed by
24 h ECG Holter or 7-day ECG recording. To ensure equal follow-up
periods, follow-up was censored at 18 months.
Figure 1 (A) Postero-anterior view of the 3D reconstructed electroanatomical map of the LA. Tubes identify PVs. (B) The same view after
ablation. Red dots identify circumferential lines of ablation around PVs.
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Ablation was deemed successful in the absence of symptomatic or
asymptomatic atrial tachyarrhythmias .30 s identified on surface
ECG, Holter monitoring or 7-day ECG recording, with or
without antiarrhythmic drug therapy. As early relapse of atrial tachyar-
rhythmias within the first 3 months after RF ablation may be a transient
phenomenon, this transition period was excluded from the final
analysis.18
Statistical analysis
Continuous variables are expressed as mean+ SD (range). Discrete
variables are presented as percentages.
Statistical analyses of the variables in the three groups were made by
means of Fisher’s exact test or x2 test for categorical variables, and by
means of ANOVA or Kruskal–Wallis test for continuous variables.
The normality of distribution of continuous variables was assessed
through visual inspection of the histograms. All tests were two-tailed.
A P-value ,0.05 was considered statistically significant.
The actuarial probability of freedom from AF recurrence after abla-
tion was calculated by applying the Kaplan–Meier method separately in
the three groups. Differences between the curves were tested for sig-
nificance by means of the log-rank statistic.
All analyses used the Statistical Package for the Social Sciences
(SPSS, version 11.0) (SPSS, Inc., Chicago, IL, USA).
Results
Clinical characteristics
The clinical characteristics of the 573 study patients are presented
in Table 1. The three groups did not differ significantly, apart from a
lower prevalence of structural heart disease in SOCA group
patients.
Procedural outcome
Procedural outcome is presented in Table 2. Of note, ablation was
performed during the first 14 months of the study more frequently
in SOCA group and CARTO group patients than in MERGE group
patients (P, 0.007), and the use of 3D electroanatomical mapping
(both CartoTM System and CartoMergeTM System) facilitated the
identification of supernumerary PVs (P, 0.0001). Thus, a higher
number of PVs were targeted in MERGE group patients than in
the other two groups (MERGE 3.92+ 0.57 vs. SOCA 3.74+
0.63 vs. CARTO 3.67+ 0.97, P, 0.03). The total procedural dur-
ation was significantly shorter in MERGE group patients than in
CARTO group patients (210.3+ 63.4 vs. 231.7+ 70.7 min, P,
0.04), but longer than in SOCA group patients (184.9+
58.4 min, P, 0.0001). However, total fluoroscopy time did not
differ among the three groups (SOCA 56.5+ 22.5 vs. CARTO
55.0+ 25.3 vs. MERGE 54.3+ 25.5 min, P ¼ 0.98).
According to the proprietary software embedded in the
CartoMergeTM, the mean distance between the points sampled
on the electroanatomical map and the closest 3D CT/MR
surface ranged from 1.67 to 2.40 mm in MERGE group patients.
Complications
Major complications occurred in 14 patients (2.4%): vascular acci-
dents in 6; PV stenosis .50% in 4, thromboembolic events in 3,
and cardiac tamponade in 1. The distribution of major compli-
cations was similar in the three groups (SOCA group 2.1%,
CARTO group 3.7%, and MERGE group 2.2%, P ¼ 0.41).
Clinical outcome
Arrhythmia burden was assessed at each follow-up visit by means of
7-day ECG recording more frequently in SOCA group and MERGE
group patients than in CARTO group patients (28.8, 35.4, and 13.1%,
respectively, P, 0.0001). Follow-up duration was similar in the
three study groups: SOCA group 11.2+ 5.2 months, CARTO
group 12.3+5.4 months, and MERGE group 11.2+4.8 months.
During follow-up, atrial tachyarrhythmias relapsed in 107/240
(44.6%) SOCA group patients and in 44/107 (41.7%) CARTO
group patients, whereas only 51/226 (22.6%) MERGE group patients
experienced recurrences (P, 0.0001). Moreover, the success rate
without antiarrhythmic drugs proved significantly higher in MERGE
group patients than in SOCA group and CARTO group patients
(43.4, 35.5, and 29.2%, respectively, P, 0.006).
Among patients who suffered relapses, the prevalence of atypical
atrial flutter/atrial tachycardia was significantly higher in the CARTO
group than in the other two groups (6.5% SOCA group patients,
15.9% CARTO group patients, and 3.9% MERGE group patients,
P ¼ 0.09).
Figure 2 (A) Postero-anterior view of the 3D MR LA surface reconstruction. (B) The same view after ablation. Red dots identify circumfer-
ential lines of ablation around PVs.
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The actuarial curves of freedom from atrial tachyarrhythmias,
with or without antiarrhythmic drugs, for each group are presented
in Figure 3. The cumulative probability of atrial tachyarrhythmia
recurrence proved significantly lower in MERGE group patients
than in SOCA group and CARTO group patients (Table 3).
Discussion
Main findings
In patients with paroxysmal AF refractory to antiarrhythmic drugs,
circumferential PV isolation guided by image integration signifi-
cantly improves clinical outcome in comparison with both circum-
ferential PV isolation guided by 3D mapping alone and segmental
electrophysiologically guided PV isolation.
The use of 3D mapping increases total procedural time and does
not reduce fluoroscopy exposure.
Clinical value of image integration
The first clinical experiences of image integration for AF ablation
stemmed from the pioneering studies of Mikaelian et al.,9 who
demonstrated that integrating LA electroanatomical maps into 3D
CT LA reconstructions was feasible. Later, the integration of elec-
troanatomical maps into CT/MR images of the LA was validated
by several studies.11,12,15
‘Registration’, which is the superimposition of the 3D CT/MR LA
image on the real-time electroanatomical map, is indicated as the
most critical issue in the entire process of image integration. We
calculated that after the registration process, the mean distance
between the points sampled on the electroanatomical map and
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Table 1 Clinical characteristics
SOCA (n5 240) CARTO (n 5 107) MERGE (n 5 226) Total
Male (%) 72.3 84.1 77.3 76.7
Age (years) 57.0+10.9 54.5+10.1 57.0+10.9 56.6+10.8
SHD (%) 21.0*,^ 28.3 30.8 26.2
Hypertension (%) 29.5 43.4 40.2 36.3
Previous TE (%) 2.1 3.1 5.6 3.2
Left atrial size (mm) 41.9+6.3 42.4+6.3 42.2+6.2 42.1+6.3
LVEF (%) 58.4+7.2 60.1+6.9 58.9+6.3 58.9+6.8
Ablation performed in the early study period (%) 57.9 52.3 43.4§ 51.1
LVEF, left ventricular ejection fraction; SHD, structural heart disease; TE, thromboembolic event.
*P ¼ 0.05 SOCA group vs. CARTO group.
^P ¼ 0.05 SOCA group vs. MERGE group.
§P, 0.007 MERGE group vs. SOCA group and MERGE group vs. CARTO group. LVEF, left ventricular ejection fraction; SHD, structural heart disease; TE, thromboembolic event.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Procedural characteristics
SOCA (n5 240) CARTO (n 5 107) MERGE (n 5 226) Total (n 5 573)
Irrigated-tip catheter (%) 96.6* 93.3^ 100 97.4
Pre-ablation MR (%) 0§ 1.9} 19.5 8.0
Pre-ablation CT (%) 17.5§ 53.5! 80.5 48.9
Procedure duration (min) 184.9+58.4§ 231.7+70.7! 210.3+63.4# 204.1+65.1
Fluoroscopy duration (min) 56.5+22.5 55.0+25.3 54.3+25.5 55.3+24.4
PV identified (n) 3.93+0.37 4.05+0.71 4.06+0.45 4.00+0.48
RF duration (min) 38.8+14.9§ 46.7+19.0! 45.7+14.9 43.0+16.0
PV targeted (n) 3.74+0.63** 3.67+0.97^^ 3.92+0.67 3.80+0.73
PV isolated (n) 3.74+0.61§§ 3.52+0.98}} 3.79+0.75 3.72+0.75
CT, computerized tomography; MR, magnetic resonance; PV, pulmonary vein; RF, radiofrequency.
*P, 0.001 SOCA group vs. MERGE group.
^P, 0.001 CARTO group vs. MERGE group.
§P, 0.0001 SOCA group vs. MERGE group.
}P, 0.0001 CARTO group vs. MERGE group.
!P, 0.0001 SOCA group vs. CARTO group.
#P, 0.04 CARTO group vs. MERGE group.
**P, 0.01 SOCA group vs. MERGE group.
^^P, 0.03 CARTO group vs. MERGE group.
§§P, 0.05 SOCA group vs. CARTO group.
}}P, 0.007 CARTO group vs. MERGE group.
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the closest 3D CT/MR surface ranged from 1.67 to 2.40 mm. Such
errors may be negligible in the clinical outcome of image-guided
ablation. Indeed, two previous studies showed that CT image inte-
gration improved the clinical outcome of AF catheter ablation in
comparison with circumferential PV isolation guided by 3D elec-
troanatomical mapping alone.13,14
However, these were both single-centre studies and enrolled a
limited number of patients. Thus, the reproducibility of their
results remains unproven. Our data, which were obtained from
573 patients enrolled in 12 centres, confirm that circumferential
PV isolation guided by image integration is clinically superior
both to circumferential PV isolation guided by 3D mapping alone
and to segmental electrophysiologically guided PV isolation.
As yet, the clinical advantage of image integration in AF ablation is
limited to improving the long-term maintenance of sinus rhythm.
Indeed, the rate of major complications proved to be similar; more-
over, fluoroscopy time was not significantly reduced, probably
owing to the prolonged duration of ablation. Not surprisingly, the
use of image integration to guide AF ablation significantly prolonged
the procedural time in comparison with simple segmental electro-
physiologically guided PV isolation. However, it should be borne
in mind that most of the centres involved in our study were using
this technique for the first time and that greater experience may
lead to a reduction in procedure duration and fluoroscopy time.
Segmental pulmonary vein isolation vs.
circumferential pulmonary vein isolation
The question of whether circumferential PV isolation is superior to
segmental PV isolation for AF ablation has not yet been
answered.19–21 Circumferential PV ablation, which combines the
elimination of PV and ostial triggers with the disruption of ganglio-
nated plexi and rotor modification, should theoretically guarantee
the best result.3 In our study, the clinical efficacy of circumferential
PV isolation guided by electroanatomical mapping was comparable
to that of segmental electrophysiologically guided PV isolation. This
could be explained by the lower number of isolated PVs recorded
in CARTO group patients than in SOCA group patients (3.52+
0.98 vs. 3.74+0.61, P, 0.05). In contrast, circumferential PV iso-
lation guided by image integration improved clinical outcome in
comparison with segmental electrophysiologically guided PV iso-
lation. Since the number of isolated PVs obtained at the end of
ablation proved to be similar (3.79+ 0.75 MERGE group vs.
3.74+0.61 SOCA group), the greater efficacy of image integration
may be explained by the possibility of delivering RF to the true PV
antrum, thanks to the availability of real images of the LA anatomy.
Conclusions
This multicentre trial demonstrated that circumferential PV iso-
lation guided by image integration is superior both to circumferen-
tial PV isolation guided by 3D mapping alone and to segmental
electrophysiologically guided PV isolation in the treatment of par-
oxysmal AF, and that this superiority is independent of the oper-
ator’s skill. True antral ablation, which eliminates PV and ostial
triggers, disrupts ganglionated plexi, and modifies rotors, can
only be performed if the LA anatomy is clearly visualized.
Study limitations
The first important limitation is that this was not a randomized
study. We cannot, therefore, exclude an enrolment bias, in that
the choice of ablation strategy may have been influenced by the
patients’ clinical characteristics. Indeed, patients who underwent
segmental PV isolation displayed lone AF more frequently than
those of the other two groups. On the other hand, as segmental
PV isolation and circumferential PV isolation guided by 3D
mapping alone were more frequently performed during the early
phase of the study, a bias related to the different learning curves
cannot be excluded.22 When performing segmental PV isolation
and circumferential PV isolation guided by 3D mapping, position
of PVs’ ostia is unknown, and ablation may be performed within
PVs in some patients. However, observational studies like this
can provide additional information, since they are fully representa-
tive of everyday clinical practice, in which several factors that are
underestimated in prospective trials, such as the different experi-
ence of the centres involved, may play a role. For this reason,
observational studies will be of particular importance in monitoring
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3 Log-rank statistic and significance of the
comparisons among atrial tachyarrhythmia-free
survival curves of the three study groups
Group CARTO MERGE
MERGE 8.37, P, 0.005
SOCA 0.62, P ¼ 0.43 21.45, P, 0.00001
Figure 3 Kaplan–Meier estimation of the time to atrial
tachyarrhythmia recurrence after ablation in MERGE group
patients (solid line), CARTO group patients (dashed line), and
SOCA group patients (dotted line). Log-rank statistic and signifi-
cance: SOCA vs. CARTO 0.62 (P ¼ 0.43); SOCA vs. MERGE
21.45 (P, 0.00001); and CARTO vs. MERGE 8.37 (P, 0.005).
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and guiding the incorporation of this therapeutic procedure into
clinical practice.
Asymptomatic AF recurrence could be underestimated during
the post-ablation follow-up since the probability of detecting tran-
sient asymptomatic arrhythmias increases directly in proportion to
the time period monitored, and 7-day ECG recording is more sen-
sitive than 24 h ECG Holter recording.23 However, in a very recent
study, none of the patients with pacemaker documentation of
post-ablation AF remained completely asymptomatic during a
follow-up period of 1 year.24 Thus, symptomatic freedom from
AF after ablation seems to correlate well with actual freedom
from AF after ablation, at least in highly symptomatic patients.
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